Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 9—September 2003


Hantavirus Infection in Humans and Rodents, Northwestern Argentina

Noemi Pini*Comments to Author , Silvana Levis*, Gladys Calderón*, Josefina Ramirez†, Daniel Bravo‡, Elena Lozano†, Carlos Ripoll§, Stephen St. Jeor¶, Thomas G. Ksiazek#, Ruben M. Barquez**††, and Delia Enria*
Author affiliations: *Instituto Nacional de Enfermedades Virales Humanas “Dr. Julio I. Maiztegui,” Pergamino, Argentina; †Hospital San Miguel, Yuto, Jujuy, Argentina; ‡Hospital Oscar Orias, Libertador General San Martín, Jujuy, Argentina; §Dirección de Epidemiología, Jujuy, Argentina; ¶University of Nevada, Reno, Nevada, USA; #Centers for Disease Control and Prevention, Atlanta, Georgia, USA; **Universidad Nacional de Tucumán, Tucumán, Argentina; ††Consejo Nacional de Investigaciones Científicas y Técnicas, Tucumán, Argentina

Main Article

Table 4

Hantavirus antibody prevalence by clinical and epidemiologic characteristics

Chi square,a p value Without data
Positive/tested (%) Positive/tested (%) Positive/tested (%)
Previous clinical HPSb symptoms
3/29 (10.3)
19/307 (6.2)
0.75, 0.38
0/5 (0)
Contact with a confirmed HPS case-patient
6c/98 (6.1)
16/242 (6.6)
0.03, 0.86
0/1 (0)
Recreational activities (fishing, hunting)
6/77 (7.8)
16/260 (6.2)
0.26, 0.60
0/4 (0)
Sighting of rodents
17/270 (6.3)
5/71 (7.0)
0.05, 0.81

Trips outside the area 15/233 (6.4) 7/105 (6.7) 0.01, 0.93 0/3 (0)

aChi-square test for comparison of two proportions in two independent samples, p>0.05 no significance. EpiInfo version 2000 (Centers for Disease Control, Atlanta, GA).
bHPS, hantavirus pulmonary syndrome.
cAll positive contacts were relatives of a confirmed HPS patient.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO